Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| USANA HEALTH SCIENCES INCUSNA · Entity 6114 | CHIEF SALES OFFICER | December 10, 2025 | December 11, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
USANA HEALTH SCIENCES INC
Report date December 10, 2025 · Filed December 11, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,387 |
Reported balance
After 2025-12-10 transaction · row 1
1 source rowRow 1 · 2025-12-10 · Sale · Disposed 873 · Balance 8,387 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 10, 2025 Filed Dec 11, 2025 16:25 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 873 | $21.00 | $18,333.00 |
DisclosureSEC source: 0001697433-25-000004 · wk-form4_1765470322.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,387 Read SEC document |
| July 30, 2025 Filed Jul 31, 2025 15:03 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 3,515 | $30.26 | $106,363.90 |
DisclosureSEC source: 0000896264-25-000200 · wk-form4_1753974190.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,260 Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 15:00 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 3,234 | $32.98 | $106,669.93 |
DisclosureSEC source: 0000896264-25-000087 · wk-form4_1741705242.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,775 F1 · price: Weighted average price $32.9839. Price ranged in multiple transactions was $32.97 to $33.01 inclusively. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 17:12 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GrantRestricted Stock Units · Derivative | 18,641 | $0.00 | $0.00 |
DisclosureSEC source: 0000896264-25-000068 · wk-form4_1741021926.xml · derivative · entry 1 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,671 Underlying: Common Stock · 18,641 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: On February 27th 2025, the reporting person was granted restricted stock units, vesting at 25% on each 27th of February thereafter. F2 · derivative.expiration_date: On February 27th 2025, the reporting person was granted restricted stock units, vesting at 25% on each 27th of February thereafter. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 13:31 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Units · Derivative | 2,573 | $0.00 | $0.00 |
DisclosureSEC source: 0000896264-25-000046 · wk-form4_1739280659.xml · derivative · entry 4 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,030 Underlying: Common Stock · 2,573 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 8th, 2024. F3 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 8th, 2024. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 13:31 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Units · Derivative | 1,677 | $0.00 | $0.00 |
DisclosureSEC source: 0000896264-25-000046 · wk-form4_1739280659.xml · derivative · entry 3 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,603 Underlying: Common Stock · 1,677 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 8th, 2021. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 8th, 2021. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 13:31 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 2,573 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000896264-25-000046 · wk-form4_1739280659.xml · nonDerivative · entry 2 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 13:31 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 1,677 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000896264-25-000046 · wk-form4_1739280659.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,436 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 23:02 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Units · Derivative | 1,557 | $0.00 | $0.00 |
DisclosureSEC source: 0000896264-25-000028 · wk-form4_1739228546.xml · derivative · entry 4 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,280 Underlying: Common Stock · 1,557 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 7th, 2022. F3 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 7th, 2022. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 23:02 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 1,557 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000896264-25-000028 · wk-form4_1739228546.xml · nonDerivative · entry 2 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 23:02 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Units · Derivative | 2,377 | $0.00 | $0.00 |
DisclosureSEC source: 0000896264-25-000028 · wk-form4_1739228546.xml · derivative · entry 3 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,837 Underlying: Common Stock · 2,377 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 6th, 2023. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 6th, 2023. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 23:02 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 2,377 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000896264-25-000028 · wk-form4_1739228546.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 17:05 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 4,311 | $47.76 | $205,871.81 |
DisclosureSEC source: 0000896264-24-000097 · wk-form4_1709571891.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,825 F1 · price: Weighted average price $47.755. Price range in multiple transactions was $47.63 to $47.89 inclusively. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 22:13 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GrantRestricted Stock Units · Derivative | 10,293 | $0.00 | $0.00 |
DisclosureSEC source: 0000896264-24-000073 · wk-form4_1707775987.xml · derivative · entry 3 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,214 Underlying: Common Stock · 10,293 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: On February 8th, 2024, the reporting person was granted restricted stock units, vesting at 25% on each 8th of February thereafter. F3 · derivative.expiration_date: On February 8th, 2024, the reporting person was granted restricted stock units, vesting at 25% on each 8th of February thereafter. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 22:13 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Units · Derivative | 1,676 | $0.00 | $0.00 |
DisclosureSEC source: 0000896264-24-000073 · wk-form4_1707775987.xml · derivative · entry 2 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,921 Underlying: Common Stock · 1,676 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 8th, 2021. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 8th, 2021. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 22:13 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 1,676 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000896264-24-000073 · wk-form4_1707775987.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 23:43 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Units · Derivative | 1,556 | $0.00 | $0.00 |
DisclosureSEC source: 0000896264-24-000053 · wk-form4_1707435820.xml · derivative · entry 4 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,597 Underlying: Common Stock · 1,556 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 7th, 2022. F3 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 7th, 2022. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 23:43 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 1,556 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000896264-24-000053 · wk-form4_1707435820.xml · nonDerivative · entry 2 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,460 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 23:43 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Units · Derivative | 2,377 | $0.00 | $0.00 |
DisclosureSEC source: 0000896264-24-000053 · wk-form4_1707435820.xml · derivative · entry 3 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,153 Underlying: Common Stock · 2,377 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 6th, 2023. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 6th, 2023. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 23:43 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 2,377 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000896264-24-000053 · wk-form4_1707435820.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| February 03, 2024 Filed Feb 6, 2024 18:16 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Units · Derivative | 1,079 | $0.00 | $0.00 |
DisclosureSEC source: 0000896264-24-000033 · wk-form4_1707243365.xml · derivative · entry 2 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,530 Underlying: Common Stock · 1,079 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 3rd, 2020. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 3rd, 2020. Read SEC document |
| February 03, 2024 Filed Feb 6, 2024 18:16 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 1,079 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000896264-24-000033 · wk-form4_1707243365.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,527 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 23:14 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 2,159 | $65.34 | $141,066.69 |
DisclosureSEC source: 0001415889-23-012331 · form4-08162023_110849.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,448 F1 · price: Weighted average price $65.3389. Price range in multiple transactions was $65.30 to $65.465 inclusively. Read SEC document |
| August 11, 2023 Filed Aug 15, 2023 15:58 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 1,080 | $66.28 | $71,585.10 |
DisclosureSEC source: 0001415889-23-012246 · form4-08152023_030826.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,607 F1 · price: Weighted average price $66.2825. Price range in multiple transactions was $66.26 to $66.30 inclusively. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 17:43 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 3,354 | $65.00 | $218,010.00 |
DisclosureSEC source: 0001415889-23-011633 · form4-08012023_050818.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,687 Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 16:07 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 1,557 | $61.00 | $94,977.00 |
DisclosureSEC source: 0001415889-23-009874 · form4-06162023_040616.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,041 Read SEC document |
| April 28, 2023 Filed Apr 28, 2023 21:49 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 1,138 | $67.40 | $76,699.38 |
DisclosureSEC source: 0001415889-23-007032 · form4-04282023_090452.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,598 F1 · price: Weighted average price $67.3984. Price range in multiple transactions was $67.395 to $67.40 inclusively. Read SEC document |
| February 08, 2023 Filed Feb 9, 2023 02:52 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Units · Derivative | 1,677 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-002188 · form4-02092023_020255.xml · derivative · entry 5 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,609 Underlying: Common Stock · 1,677 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F4 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 8th, 2021. F4 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 8th, 2021. Read SEC document |
| February 08, 2023 Filed Feb 9, 2023 02:52 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 1,677 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-002188 · form4-02092023_020255.xml · nonDerivative · entry 2 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,736 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 02:52 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Units · Derivative | 1,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-002188 · form4-02092023_020255.xml · derivative · entry 4 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,286 Underlying: Common Stock · 1,557 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 7th, 2022. F3 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 7th, 2022. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 02:52 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 1,557 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-002188 · form4-02092023_020255.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| February 06, 2023 Filed Feb 9, 2023 02:52 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GrantRestricted Stock Units · Derivative | 9,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-002188 · form4-02092023_020255.xml · derivative · entry 3 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,843 Underlying: Common Stock · 9,508 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: On February 6th, 2023, the reporting person was granted restricted stock units, vesting at 25% on each 6th of February thereafter. F2 · derivative.expiration_date: On February 6th, 2023, the reporting person was granted restricted stock units, vesting at 25% on each 6th of February thereafter. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 18:02 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Units · Derivative | 1,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-002060 · form4-02072023_060203.xml · derivative · entry 4 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,335 Underlying: Common Stock · 1,138 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F4 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. F4 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 18:02 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 1,138 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-002060 · form4-02072023_060203.xml · nonDerivative · entry 2 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 18:02 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Units · Derivative | 1,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-002060 · form4-02072023_060203.xml · derivative · entry 3 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,473 Underlying: Common Stock · 1,080 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 3rd, 2020. F3 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 3rd, 2020. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 18:02 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 1,080 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-002060 · form4-02072023_060203.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · CHIEF SALES OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,364 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · balance_after: Includes an adjustment of 90 shares owned by the reporting person, which were over reported on the previous Form 4. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 20:03 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Units · Derivative | 1,677 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000986 · edgar.xml · derivative · entry 3 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,553 Underlying: Common Stock · 1,677 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 8th, 2021. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 8th, 2021. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 20:03 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 1,677 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-000986 · edgar.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| February 07, 2022 Filed Feb 10, 2022 20:03 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GrantRestricted Stock Units · Derivative | 6,226 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000986 · edgar.xml · derivative · entry 2 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,230 Underlying: Common Stock · 6,226 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: On February 7th, 2022, the reporting person was granted restricted stock units, vesting at 25% on each 7th of February thereafter. F3 · derivative.expiration_date: On February 7th, 2022, the reporting person was granted restricted stock units, vesting at 25% on each 7th of February thereafter. Read SEC document |
| February 05, 2022 Filed Feb 8, 2022 23:29 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Units · Derivative | 1,399 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000935 · edgar.xml · derivative · entry 6 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,004 Underlying: Common Stock · 1,399 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. F3 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. Read SEC document |
| February 05, 2022 Filed Feb 8, 2022 23:29 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 1,399 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-000935 · edgar.xml · nonDerivative · entry 3 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,697 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 23:29 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Units · Derivative | 1,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000935 · edgar.xml · derivative · entry 5 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,403 Underlying: Common Stock · 1,138 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 23:29 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 1,138 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-000935 · edgar.xml · nonDerivative · entry 2 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| February 03, 2022 Filed Feb 8, 2022 23:29 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Units · Derivative | 1,079 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000935 · edgar.xml · derivative · entry 4 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,541 Underlying: Common Stock · 1,079 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F4 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 3rd, 2020. F4 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 3rd, 2020. Read SEC document |
| February 03, 2022 Filed Feb 8, 2022 23:29 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 1,079 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-000935 · edgar.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,160 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| December 07, 2021 Filed Dec 8, 2021 22:16 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 873 | $101.50 | $88,609.50 |
DisclosureSEC source: 0001179110-21-010696 · edgar.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,081 Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 15:48 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 569 | $102.00 | $58,038.00 |
DisclosureSEC source: 0001179110-21-010157 · edgar.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,954 Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 21:05 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 1,111 | $100.74 | $111,922.14 |
DisclosureSEC source: 0001179110-21-010088 · edgar.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,523 F1 · price: Weighted average price $100.74. Price range in multiple transactions was $100.47 to $101.00 inclusively. Read SEC document |
| November 04, 2021 Filed Nov 8, 2021 19:27 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 1,398 | $101.77 | $142,274.46 |
DisclosureSEC source: 0001179110-21-009923 · edgar.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,634 F1 · price: Weighted average price $101.77. Price range in multiple transactions was $101.54 to $102.00 inclusively. Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:24 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 1,277 | $99.63 | $127,233.51 |
DisclosureSEC source: 0001179110-21-009889 · edgar.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,032 F1 · price: Weighted average price $99.6347. Price range in multiple transactions was $99.27 to $100.00 inclusively. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.